These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 15495097

  • 1. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Shrivastava R.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097
    [Abstract] [Full Text] [Related]

  • 2. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598
    [Abstract] [Full Text] [Related]

  • 3. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD004289. PubMed ID: 19588351
    [Abstract] [Full Text] [Related]

  • 4. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD005019. PubMed ID: 19370615
    [Abstract] [Full Text] [Related]

  • 5. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Jan 28; 2014(1):CD005019. PubMed ID: 24470059
    [Abstract] [Full Text] [Related]

  • 6. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007784. PubMed ID: 19370693
    [Abstract] [Full Text] [Related]

  • 7. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2013 Sep 11; 2013(9):CD004289. PubMed ID: 24022428
    [Abstract] [Full Text] [Related]

  • 8. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 May 31; (5):CD007784. PubMed ID: 24880031
    [Abstract] [Full Text] [Related]

  • 10.
    Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.
    ; 2016 08 31. PubMed ID: 27559556
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of statin therapy in maintenance dialysis patients.
    Sun L, Zou L, Chen M, Liu B.
    Ren Fail; 2015 Aug 31; 37(7):1149-56. PubMed ID: 26139229
    [Abstract] [Full Text] [Related]

  • 12. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
    Vale L, Cody J, Wallace S, Daly C, Campbell M, Grant A, Khan I, Donaldson C, Macleod A.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD003963. PubMed ID: 15495072
    [Abstract] [Full Text] [Related]

  • 13. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
    Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.
    BMJ; 2008 Mar 22; 336(7645):645-51. PubMed ID: 18299289
    [Abstract] [Full Text] [Related]

  • 14. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
    Strippoli GF, Manno C, Schena FP, Craig JC.
    Cochrane Database Syst Rev; 2003 Mar 22; (1):CD003967. PubMed ID: 12535495
    [Abstract] [Full Text] [Related]

  • 15. Statins for the prevention of dementia.
    McGuinness B, Craig D, Bullock R, Passmore P.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD003160. PubMed ID: 19370582
    [Abstract] [Full Text] [Related]

  • 16. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A.
    Cochrane Database Syst Rev; 2002 Apr 15; (4):CD003895. PubMed ID: 12519614
    [Abstract] [Full Text] [Related]

  • 17. Preoperative statin therapy for patients undergoing cardiac surgery.
    Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ.
    Cochrane Database Syst Rev; 2015 Aug 13; (8):CD008493. PubMed ID: 26270008
    [Abstract] [Full Text] [Related]

  • 18. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
    Vale L, Cody J, Wallace S, Daly C, Campbell M, Grant A, Khan I, Donaldson C, MacLeod A.
    Cochrane Database Syst Rev; 2003 Aug 13; (1):CD003963. PubMed ID: 12535493
    [Abstract] [Full Text] [Related]

  • 19. Statins for the primary prevention of cardiovascular disease.
    Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD004816. PubMed ID: 21249663
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive agents for treating IgA nephropathy.
    Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA.
    Cochrane Database Syst Rev; 2003 Jan 19; (4):CD003965. PubMed ID: 14584001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.